Clinical Trial

Aveir VR Coverage With Evidence Development Post-Approval Study

Study acronym: CED
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this coverage with evidence development (CED) study is to evaluate complications and long-term health outcomes of the single-chamber Aveir Single-Chamber Leadless Pacemaker device (Aveir VR LP).
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-04-19; most recent amendment 2025-07-29.
Status change: Not Yet Recruiting → Recruiting 2022-08-09
Status change: Withheld → Not Yet Recruiting 2022-06-13
Trial Details
NCT Number NCT05336877
Lead Sponsor Abbott Medical Devices
Conditions Cardiac Pacemaker, Arrythmia, Bradycardia
Enrollment 8,744 participants
Start Date 2022-06-21
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-31